このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Wave Life Sciences マネジメント
マネジメント 基準チェック /34
Wave Life Sciences'の CEO はPaul B. Bolnoで、 Dec2013年に任命され、 の在任期間は 10.67年です。 の年間総報酬は$ 3.87Mで、 16.4%給与と83.6%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.33%を直接所有しており、その価値は$ 2.31M 。経営陣と取締役会の平均在任期間はそれぞれ3.7年と7.8年です。
主要情報
Paul B. Bolno
最高経営責任者
US$3.9m
報酬総額
| CEO給与比率 | 16.4% |
| CEO在任期間 | 10.8yrs |
| CEOの所有権 | 0.3% |
| 経営陣の平均在職期間 | 3.8yrs |
| 取締役会の平均在任期間 | 7.8yrs |
経営陣の近況
Recent updates
There's Reason For Concern Over Wave Life Sciences Ltd.'s (NASDAQ:WVE) Massive 43% Price Jump
Sep 25
Wave Life Sciences: Spiking On Strong DMD Data, But Not Fully De-Risked Yet
Sep 24Broker Revenue Forecasts For Wave Life Sciences Ltd. (NASDAQ:WVE) Are Surging Higher
Sep 08We're Keeping An Eye On Wave Life Sciences' (NASDAQ:WVE) Cash Burn Rate
Aug 05Pinning Down Wave Life Sciences Ltd.'s (NASDAQ:WVE) P/S Is Difficult Right Now
Jun 25We Think Wave Life Sciences (NASDAQ:WVE) Can Easily Afford To Drive Business Growth
Apr 09Wave Life Sciences' Weighty Ambition: Carving Out Obesity Niche
Mar 09Wave Life Sciences Ltd.'s (NASDAQ:WVE) 30% Price Boost Is Out Of Tune With Revenues
Mar 03We're Interested To See How Wave Life Sciences (NASDAQ:WVE) Uses Its Cash Hoard To Grow
Sep 13Wave Life Sciences Ltd. (NASDAQ:WVE) Analysts Just Cut Their EPS Forecasts Substantially
May 08Here's Why Wave Life Sciences (NASDAQ:WVE) Must Use Its Cash Wisely
Mar 30Are Investors Undervaluing Wave Life Sciences Ltd. (NASDAQ:WVE) By 47%?
Jan 20Some Analysts Just Cut Their Wave Life Sciences Ltd. (NASDAQ:WVE) Estimates
Nov 11Is Wave Life Sciences (NASDAQ:WVE) In A Good Position To Deliver On Growth Plans?
Aug 12Wave Life Sciences Q2 2022 Earnings Preview
Aug 10Will Wave Life Sciences (NASDAQ:WVE) Spend Its Cash Wisely?
Apr 21Is Wave Life Sciences (NASDAQ:WVE) In A Good Position To Invest In Growth?
Jan 11We Think Wave Life Sciences (NASDAQ:WVE) Needs To Drive Business Growth Carefully
Sep 24What Does The Future Hold For Wave Life Sciences Ltd. (NASDAQ:WVE)? These Analysts Have Been Cutting Their Estimates
Aug 07CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$73m |
| Mar 31 2024 | n/a | n/a | -US$62m |
| Dec 31 2023 | US$4m | US$636k | -US$58m |
| Sep 30 2023 | n/a | n/a | -US$85m |
| Jun 30 2023 | n/a | n/a | -US$131m |
| Mar 31 2023 | n/a | n/a | -US$151m |
| Dec 31 2022 | US$3m | US$618k | -US$162m |
| Sep 30 2022 | n/a | n/a | -US$153m |
| Jun 30 2022 | n/a | n/a | -US$120m |
| Mar 31 2022 | n/a | n/a | -US$118m |
| Dec 31 2021 | US$4m | US$597k | -US$122m |
| Sep 30 2021 | n/a | n/a | -US$116m |
| Jun 30 2021 | n/a | n/a | -US$143m |
| Mar 31 2021 | n/a | n/a | -US$145m |
| Dec 31 2020 | US$1m | US$579k | -US$150m |
| Sep 30 2020 | n/a | n/a | -US$178m |
| Jun 30 2020 | n/a | n/a | -US$196m |
| Mar 31 2020 | n/a | n/a | -US$197m |
| Dec 31 2019 | US$4m | US$579k | -US$194m |
| Sep 30 2019 | n/a | n/a | -US$175m |
| Jun 30 2019 | n/a | n/a | -US$162m |
| Mar 31 2019 | n/a | n/a | -US$156m |
| Dec 31 2018 | US$6m | US$541k | -US$147m |
| Sep 30 2018 | n/a | n/a | -US$140m |
| Jun 30 2018 | n/a | n/a | -US$127m |
| Mar 31 2018 | n/a | n/a | -US$116m |
| Dec 31 2017 | US$3m | US$515k | -US$102m |
報酬と市場: Paul B.の 総報酬 ($USD 3.87M ) は、 US市場 ($USD 3.30M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Paul B.の報酬は増加しましたが、会社は利益を上げていません。
CEO（最高経営責任者
Paul B. Bolno (50 yo)
10.8yrs
在職期間
US$3,874,300
報酬
Dr. Paul B. Bolno, M.D., MBA served as an Independent Director at SQZ Biotechnologies Company since June 2020 until March 2024. Since May 2020 he has served as Chairman of the Scientific Advisory Group for...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 10.8yrs | US$3.87m | 0.29% $ 3.0m | |
| CFO & Principal Accounting Officer | 3.8yrs | US$1.70m | 0.014% $ 142.2k | |
| Chief Technology Officer | 4.3yrs | US$1.78m | 0.15% $ 1.5m | |
| Chief Scientific Officer | less than a year | データなし | データなし | |
| Head of Investor Relations | 5.4yrs | データなし | データなし | |
| Senior VP & General Counsel | 8.3yrs | データなし | データなし | |
| Senior VP of Corporate Development & Head of Emerging Areas | 7.7yrs | US$1.68m | 0.064% $ 660.9k | |
| Senior VP & Head of Human Resources | 1.7yrs | データなし | データなし | |
| Senior Vice President of Chemistry | 2.8yrs | データなし | データなし | |
| Chief Development Officer | 1.9yrs | データなし | データなし | |
| Senior Vice President of Translational Medicine | 1.7yrs | データなし | データなし |
3.8yrs
平均在職期間
51.5yo
平均年齢
経験豊富な経営陣: WVEの経営陣は 経験豊富 であると考えられます ( 3.7年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 10.4yrs | US$3.87m | 0.29% $ 3.0m | |
| Director | 11.2yrs | US$170.74k | 0.024% $ 248.7k | |
| Independent Director | 5yrs | US$194.74k | 0.095% $ 982.4k | |
| Independent Chairperson | 7.8yrs | US$222.24k | 0.10% $ 1.1m | |
| Independent Director | 7.6yrs | US$188.74k | 0.10% $ 1.1m | |
| Independent Director | 9.7yrs | US$170.74k | データなし | |
| Independent Director | 12.2yrs | US$170.74k | 0% $ 0 | |
| Independent Director | 5yrs | US$185.74k | 0.095% $ 982.4k | |
| Independent Director | 4.1yrs | US$172.24k | 0.085% $ 875.2k |
7.8yrs
平均在職期間
56yo
平均年齢
経験豊富なボード: WVEの 取締役会 は 経験豊富 であると考えられます ( 7.8年の平均在任期間)。